Morning Market Movers
October 06, 2014 at 09:42 AM EDT
Durata Therapeutics (NASDAQ: DRTX) shares gained 72.91% to $24.00 after Actavis (NYSE: ACT) announced its plans to buy Durata ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.